共 247 条
[1]
Whelan TJ(2010)Long-term results of hypofractionated radiation therapy for breast cancer N Engl J Med 362 513-520
[2]
Pignol JP(2013)The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials Lancet Oncol 14 1086-1094
[3]
Levine MN(2011)Fractionation for whole breast irradiation: an American society for radiation oncology (ASTRO) evidence-based guideline Int J Radiat Oncol Biol Phys 81 59-68
[4]
Julian JA(2018)Radiation therapy for the whole breast: executive summary of an American society for radiation oncology (ASTRO) evidence-based guideline Pract Radiat Oncol 8 145-152
[5]
MacKenzie R(2021)Final analysis of a multicenter single-arm confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906 Jpn J Clin Oncol 51 865-872
[6]
Parpia S(2014)Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast Int J Radiat Oncol Biol Phys 90 1017-1024
[7]
Haviland JS(2020)Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial J Clin Oncol 38 3615-3625
[8]
Owen JR(2015)Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial Lancet Oncol 16 47-56
[9]
Dewar JA(2019)The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation Radiat Oncol 14 121-497
[10]
Agrawal RK(2013)Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis Int J Radiat Oncol Biol Phys 86 491-1068